Cite
HARVARD Citation
Zhang, X. et al. (2014). Dipeptidyl Peptidase-4 Inhibitors as a Third-Line Oral Antihyperglycaemic Agent in Patients with Type 2 Diabetes Mellitus: The Impact of Ethnicity. International journal of endocrinology. p. . [Online].